Scotland starts newborn screening for SMA

As part of a two-year evaluation funded by the Scottish government and Novartis, Scotland will screen newborn babies for Spinal Muscular Atrophy (SMA) from 23 March 2026. Scotland will offer all parents SMA screening for their newborns as part of the routine blood spot test carried around four days after birth, the first part of […] The post Scotland starts newborn screening for SMA appeared first on Pharmafile.

Continue reading →